Evidence map›Paper›PMID 38835407›Full record

ArticleKidney diseases (Basel, Switzerland)2024

Combined Genetic Association and Differed Expression Analysis of

Lin-Lin Xu, Ting Gan, Yang Li, Pei Chen, Su-Fang Shi, Li-Jun Liu, Ji-Cheng Lv, Hong Zhang, Xu-Jie Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney diseases (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lin-Lin XuRenal Division, Peking University First Hospital, Beijing, China.
Ting GanRenal Division, Peking University First Hospital, Beijing, China.
Yang LiRenal Division, Peking University First Hospital, Beijing, China.
Pei ChenRenal Division, Peking University First Hospital, Beijing, China.
Su-Fang ShiRenal Division, Peking University First Hospital, Beijing, China.
Li-Jun LiuRenal Division, Peking University First Hospital, Beijing, China.
Ji-Cheng LvRenal Division, Peking University First Hospital, Beijing, China.
Hong ZhangRenal Division, Peking University First Hospital, Beijing, China.
Xu-Jie ZhouRenal Division, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: IgA nephropathy (IgAN) is a leading cause of end-stage renal disease. The exact pathogenesis of IgAN is not well defined, but some genetic studies have led to a novel discovery that the (immuno)proteasome probably plays an important role in IgAN. Methods: We firstly analyzed the association of variants in the Results: The rs131654 showed the most significant association signal in Conclusion: In conclusion, by combined genetic association and differed expression analysis of

Indexed as

IgA nephropathyImmunoproteasomeUbiquitin-conjugating enzymeUbiquitin-proteasome system

Identifiers

PMID38835407
PMCPMC11149991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.